REBISTART: Adherence of Patients with Multiple Sclerosis to Treatment with Subcutaneous Interferon Beta in the Context of a Patient Support Program.

Neurol Ther · 2024 · PMC11136908 · PMID 38530606

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

The highly significant correlations of self-assessed adherence based on the VAS and the MMAS results and those between self-assessed adherence based on the VAS and the objective adherence based on the RebiSmart ® ID readouts support the validity of the VAS for assessment of adherence.

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.